nobligan retard 100 mg
grünenthal gmbh - tramadolhydroklorid - depottablett - 100 mg
nobligan retard 150 mg
grünenthal gmbh - tramadolhydroklorid - depottablett - 150 mg
nobligan retard 200 mg
grünenthal gmbh - tramadolhydroklorid - depottablett - 200 mg
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).
kentera (previously oxybutynin nicobrand)
teva b.v. - oksybutynin - urininkontinens, trang - urologika - symptomatisk behandling av tranginkontinens og / eller økt urinfrekvens og haster som kan oppstå hos voksne pasienter med ustabil blære.
tovanor breezhaler
novartis europharm limited - glycopyrronium bromide - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - tovanor breezhaler er indikert som en vedlikeholdsbronkodilatorbehandling for å lindre symptomer hos voksne pasienter med kronisk obstruktiv lungesykdom (kol).
xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
zurampic
grünenthal gmbh - lesinurad - hyperuricemia - antigout preparater - zurampic, er i kombinasjon med en xantin oksidase, angitt i voksne for tilleggsbehandling behandling av hyperuricaemia i gikt pasienter (med eller uten tophi) som ikke har oppnådd målet serum urinsyre nivå med en tilstrekkelig dose av en xantin oksidase hemmer alene.